Immunotherapy toxicities: An SGO clinical practice statement

Gynecol Oncol. 2022 Jul;166(1):25-35. doi: 10.1016/j.ygyno.2022.05.003. Epub 2022 May 18.
No abstract available

Keywords: Cervical cancer; Checkpoint blockade; Endometrial cancer; Immunotherapy; Pembrolizumab; Toxicity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Humans
  • Immunotherapy* / adverse effects
  • Programmed Cell Death 1 Receptor*

Substances

  • Programmed Cell Death 1 Receptor